top of page

INITIATIVES

iStock_000074468145_XXXLarge.jpg

Global Regulatory Review and Outreach Workstream

Workstream Objectives

​

  • Stay abreast of regulatory developments for OINDPs.

  • Understand requirements for OINDPs in emerging markets.

  • Engage in outreach to regulatory agencies, pharmacopeias, and other standard-setting bodies worldwide, as appropriate.

  • Monitor and address, as appropriate, environmental and sustainability priorities. 

​

Working Groups

​​

  • GRRO Brazil

  • GRRO China

  • GRRO Europe

  • GRRO North America

  • GRRO Alternate Propellants (AP)

conference.JPG

External Outreach Workstream

Workstream Objectives

​

  • Grow and evolve membership to ensure IPAC-RS is equipped to address current and future challenges. 

  • Develop and implement visibility and outreach strategies to achieve growth goals.

  • Advance the science and scientific discourse between IPAC-RS and external stakeholders in areas of common interest. 

  • Collaborate with other trade groups on relevant issues.

  • Increase public visibility of IPAC-RS advocacy, technical work, and subject matter expertise. 

​

Working Groups

​

  • Membership Committee

  • Roundtables, webinar, and conferences with key stakeholders and thought leaders

  • Collaborations with other organizations, as appropriate (e.g., ISAM, RDD, DDL, EPAG, AAPS, IPAC, and PQRI)

initiative_cmc.png

Product Development Workstream

Workstream Objectives

​

  • Monitor, assess, and respond to regulatory developments related to chemisty, manufacturing, and controls (CMC) and product development for small/synthetic molecules as well as large molecules and biologics.

  • Develop improved approaches, “best practices” and other recommendations for CMC and product development analytical testing, formulation, manufacturing, stability, material selection, product characterization, and other topics.

​

Working Groups and Knowledge Networks

​

gettyimages-103583201-2048x2048.jpg

Delivery Systems Workstream

Workstream Objectives

​

  • Develop and share industry practices and monitor regulatory developments related to OINDP devices and device-patient interface, and container-closure systems.

  • Develop and promulgate device-related recommendations for OINDP industry, device manufacturers, regulators, health-care providers, patients and other potential stakeholders.

  • Explore and collaboratively address challenges related to nasal delivery systems.

  • Discuss and publish considerations for materials selection and quality with new propellants.

  • Examine regulatory requirements related to change management, starting with Europe and thereafter in the US and later ini other world regions.  Promote streamlining and harmonization of requirements.

​

Working Groups

​

  • OINDP Materials

  • Materials and Propellants Quality Considerations

  • Change Management

  • Nasal WG and subteams

bottom of page